On November 14, 2016, Spectrum Pharmaceuticals, Inc. issued a
press release, which, among other matters, sets forth our results
of operations for the quarter ended September 30, 2016. A copy of
the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.

The foregoing information, including Exhibit 99.1, is being
furnished under Item 2.02 and shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liability of that section,
nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

>>>>>>>>>(d) Exhibits.